跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-CEFEPIME - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
APO-CEFEPIME
Authorized
STANDARD
APO-CEFEPIME
Apotex Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
622db936780b9e38
Company
Apotex Inc
Type
Standard
Approval Details
Approval Id
622db936780b9e38
Drug Approval Canada Name
APO-CEFEPIME
Product Name
APO-CEFEPIME
Status
Marketed
Status Date
2018-05-14
Original Market Date
2018-05-14
Din
02467496
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous , Intramuscular
Schedule
Prescription
Ahfs
08:12.06.16
Atc Original
J01DE01 CEFEPIME
Atc Name
j 01 de 01
Aig Number
0150504004
Company Name
Apotex Inc
Company Address
150 Signet Drive, Toronto, Ontario, Canada, M9L 1T9
Company Detail Path
/organization/apotex-inc
Company Information
Pharmaceutical Company Name
Apotex Inc
Country Name
Canada
Province Name
Ontario
City Name
toronto,ontario,country_ca
Address
150 Signet Dr
Active Ingredients
CEFEPIME (CEFEPIME HYDROCHLORIDE)
1 G / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
622db936780b9e38
Type
Standard
Back to Health Canada Approvals